Roth Capital Reiterates Buy Following Neogen Corp's (NEOG) Mixed 2Q Results
Roth Capital reiterated a Buy rating on Neogen (NASDAQ: NEOG), and raised the price target to $68.00 (from $65.00), following ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
